Clinical & Pharmacovigilance

Clinical & Pharmacovigilance in Pharma: Ensuring Patient Safety from Trials to Market

Clinical Research involves the study of drug candidates in humans to establish safety, efficacy, pharmacokinetics, and pharmacodynamics. It includes planning, executing, and monitoring clinical trials across Phases I–IV.Click to read…

Safety Signal Delays? Clinical and PV Process Solutions

Identifying the symptoms of delays in safety signal responses is the first step in mitigating potential risks associated with pharmacovigilance. Below are common signals observed in clinical and pharmacovigilance setups:Click…

Case processing backlog during signal review – preventing repeat PV findings

The initial indicators of a case processing backlog are often seen through operational metrics, team performance, and regulatory warnings. Key symptoms include:Click to read the full article.

Safety signal escalation delay during audit response – CAPA for PV system weaknesses

Recognizing the symptoms or signals that indicate a delay in safety signal escalation is the first step in the investigation process. Symptoms can manifest in various forms, including:Click to read…

Literature surveillance failure during signal review – CAPA for PV system weaknesses

The initial step in addressing literature surveillance failures during signal review is recognizing the symptoms or signals that may indicate a failure. These signals may arise from various sources, including:Click…

AE reporting non-compliance during benefit–risk assessment – how to strengthen benefit–risk documentation

Recognizing symptoms or signals indicative of AE reporting non-compliance is crucial. Common signs include:Click to read the full article.

Safety signal escalation delay during signal review – preventing repeat PV findings

Identifying symptoms and signals related to safety signal escalation delays is the first step in addressing the issue. Symptoms often manifest in the following ways:Click to read the full article.

Risk management plan gaps during audit response – inspection questioning scenarios

Recognizing the early signs of risk management plan gaps is crucial. Symptoms may arise from various sources, including employee reports, audit findings, or negative trends in compliance metrics. Some common…

AE reporting non-compliance during inspection – preventing repeat PV findings

Identifying symptoms associated with AE reporting non-compliance is the initial step in effective investigation. Symptoms may manifest in various ways, including:Click to read the full article.

PV system audit finding during benefit–risk assessment – preventing repeat PV findings

Symptoms or signals indicating a potential problem in a PV system can manifest in various ways. Recognizing these early signs is key to initiating an effective investigation. Common indicators include:Click…

PV system audit finding during inspection – regulatory enforcement risk and mitigation

Identifying early signals of problems associated with PV system audits is crucial for prompt action. Symptoms may manifest as:Click to read the full article.

AE reporting non-compliance during benefit–risk assessment – inspection questioning scenarios

Identifying the symptoms of AE reporting non-compliance is crucial for timely intervention. Common signals include:Click to read the full article.